Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2026-03-11 @ 9:10 PM
Study NCT ID:
NCT03127956
Status:
COMPLETED
Last Update Posted:
2021-07-20
First Post:
2017-04-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
Sponsor:
Dermira, Inc.
Organization:
Study Overview
Official Title:
An Open-Label Study Assessing Long-Term Safety of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
Status:
COMPLETED
Status Verified Date:
2021-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to assess the long-term safety of Olumacostat Glasaretil gel, 5.0% in patients with acne vulgaris
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: